Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human KRT12 Protein, N-His-SUMO

Recombinant Human KRT12 Protein, N-His-SUMO from ProteoGenix; catalogue ARO-P11230; research use only.

SKU:
ABM141669-1
Manufacturer SKU
ARO-P11230
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction to Recombinant Human KRT12 Protein

Recombinant Human KRT12 Protein, also known as Keratin 12, is a protein that is encoded by the KRT12 gene in humans. It belongs to the keratin family of proteins, which are important structural components of epithelial cells. These proteins are responsible for providing strength and integrity to the cells, and play a crucial role in the maintenance and protection of various tissues in the body.

Structure of Recombinant Human KRT12 Protein

Recombinant Human KRT12 Protein is a 53 kDa protein that is composed of 480 amino acids. It is a type I keratin, which means it has a molecular weight of approximately 40-65 kDa and is found in the acidic keratin fraction. The protein has a highly conserved structure, with a central alpha-helical rod domain that is flanked by non-helical head and tail domains. This structure is characteristic of all keratin proteins and is important for their function.

Activity of Recombinant Human KRT12 Protein

Recombinant Human KRT12 Protein is primarily expressed in the cornea, which is the transparent outer layer of the eye. It is also found in the conjunctiva, a mucous membrane that covers the front of the eye and lines the inside of the eyelids. The main function of KRT12 is to provide structural support and protection to these tissues. It forms intermediate filaments, along with other keratin proteins, which are essential for maintaining the structural integrity of the cornea and conjunctiva.

In addition to its structural role, Recombinant Human KRT12 Protein also plays a role in cell signaling and differentiation. Studies have shown that KRT12 is involved in the regulation of cell proliferation and migration, as well as wound healing in the cornea. It also has antimicrobial properties, which help protect the eye from infections.

Application of Recombinant Human KRT12 Protein

Recombinant Human KRT12 Protein has several potential applications in the field of ophthalmology. One of the main applications is in the treatment of corneal diseases and injuries. Mutations in the KRT12 gene have been linked to various corneal disorders, such as Meesmann corneal dystrophy and corneal epithelial fragility syndrome. Recombinant Human KRT12 Protein can be used to replace the defective or missing KRT12 protein in these conditions, providing structural support and improving the function of the cornea.

In addition, Recombinant Human KRT12 Protein can also be used in tissue engineering and regenerative medicine. It has been shown to promote the growth and differentiation of corneal epithelial cells, which are crucial for the repair and regeneration of damaged corneal tissue. This makes it a promising candidate for developing new therapies for corneal injuries and diseases.

Furthermore, Recombinant Human KRT12 Protein can also be used as an antigen in diagnostic tests for corneal diseases. Antibodies against KRT12 can be used to detect the presence of the protein in tissue samples, which can aid in the diagnosis and monitoring of corneal disorders.

Conclusion

In summary, Recombinant Human KRT12 Protein is a vital component of the cornea and conjunctiva, playing a crucial role in maintaining the structural integrity of these tissues. Its potential applications in the treatment of corneal diseases and injuries, as well as in tissue engineering and diagnostics, make it a valuable protein in the field of ophthalmology. Further research on the structure, activity and function of KRT12 will provide a better understanding of its role in maintaining the health of the eye and may lead to the development of new therapies for corneal disorders.

ProteoGenix catalogue number ARO-P11230. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 22.81 kDa; Fragment: Gly103-Gln199; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
Keratin-12, Keratin, type I cytoskeletal 12, Cytokeratin-12, K12, CK-12, KRT12
Host species
E. coli
Source organism
Human
Molecular weight
22.81 kDa
Sequence fragment
Gly103-Gln199
Sequence
GSPGGGSLGILSGNDGGLLSGSEKETMQNLNDRLASYLDKVRALEEANTELENKIREWYETRGTGTADASQSDYSKYYPLIEDLRNKIISASI
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P11230
UniProt accession
Q99456
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£205.00£164.00